EMR vs CTAS — Key Metrics
| Metric | EMR (EMERSON ELECTRIC CO) | CTAS (CINTAS CORP) |
|---|---|---|
| Price | 162.0 | 222.0 |
| Market Cap | 88.87 Billion | 88.15 Billion |
| P/E (TTM) | 33.68 | 43.36 |
| P/B (Quarterly) | 4.484 | 15.044 |
| P/S (TTM) | 4.68 | 7.63 |
| Net Profit Margin (TTM) | 14.2 | 17.8 |
| Gross Margin (TTM) | 53.4 | 51.0 |
| ROE (TTM) | 13.2 | 42.1 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Underperform
Greatly Underperform
Recommendation Summary
Both stocks are projected to greatly underperform the market over the next year. If you have to make a choice, Upfront Recommendation: EMR.
Financial Metrics
| EMR | Metrics | CTAS |
|---|---|---|
| $162.00 | Price | $222.00 |
| — | Market Capitalization | — |
| 33.68 | Price to Earnings Ratio | 43.36 |
| 4.68 | Price to Sales | 7.63 |
| 25.14 | Price to FCF Ratio | 43.35 |
| 8.78 | Price to Gross Profit | 14.95 |
| 9.34 | Price to Current Assets | 22.42 |
EMR vs CTAS at a glance
Emerson Electric CO (EMR) and Cintas Corp (CTAS) are both in the Industrials sector. They are similar in size: $88.9 billion and $88.2 billion in market value.
On trailing-twelve-month figures, EMR trades at 33.7 times trailing earnings and CTAS at 43.4; net profit margins are 14.2% and 17.8%.
The Upfront Investment model currently rates both Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.